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Suicide and suicide attempts in people with
severe mental disorders in Butajira, Ethiopia:
10 year follow-up of a population-based cohort
Teshome Shibre1,2, Charlotte Hanlon1,3, Girmay Medhin4, Atalay Alem1, Derege Kebede4,5,6, Solomon Teferra1,
Gunnar Kullgren7, Lars Jacobsson7 and Abebaw Fekadu1,8,9*
Abstract
Background: People with severe mental disorders (SMD) are at higher risk of suicide. However, research into
suicide attempts and completed suicide in people with SMD in low- and middle-income countries is mostly limited
to patients attending psychiatric facilities where selection bias is likely to be high.
Methods: A population-based cohort of 919 people with SMD from rural Ethiopia (who received standardized
clinician diagnoses of schizophrenia (n = 358) major depressive disorder (n = 216) and bipolar I disorder (n = 345))
were followed up annually for an average of 10 years. The Longitudinal Interval Follow-up Evaluation chart was
administered by psychiatrists and used to evaluate systematically suicidal behavior and risk factors, which may be
amenable to intervention.
Results: Over the follow-up period, the cumulative risk of suicide attempt was 26.3% for major depression, 23.8% for
bipolar I disorder and 13.1% for schizophrenia, (p < 0.001). The overall incidence of completed suicide was 200.2/
100,000 person-years (CI = 120.6, 312.5). Hanging was the most frequent method used (71.5%) for both attempters and
completers. Most people who completed suicide were successful on the first attempt (84.2%), but the case-fatality rate
for suicide attempt was 9.7%. In the adjusted logistic regression model, being currently married (Adjusted OR) =2.17, 95%
CI = 1.21, 3.91), and having a diagnosis of bipolar I disorder (Adjusted OR = 2.59, 95% CI = 1.57, 4.26) or major depression
(Adjusted OR = 2.71, 95% CI = 1.60, 4.58) were associated significantly with increased risk of suicide attempts.
Conclusion: In this sample of people with SMD from a rural setting, the rate of suicide was high. Initiatives to integrate
mental health service into primary care need to focus on limiting access to suicide methods in people with SMD in
addition to expanding access to mental health care.
Keywords: Suicide, Schizophrenia, Major depression, Bipolar I disorder, Developing countries, sub-Saharan Africa, Ethiopia
Background
Suicidal behavior is a major contributor to morbidity and
mortality worldwide. Over 760,000 (85%) suicides occur in
low and middle-income countries (LMICs) [1]. Over 90%
of all suicides are believed to occur in the context of men-
tal disorders [2-7] mostly mood disorders, and alcohol and
substance use disorders [7,8]. Severe mental disorders
(SMDs), including schizophrenia, bipolar disorder and
psychotic depression), are associated with increased risk of
suicide and suicide attempts compared to the general popu-
lation [7,9,10]. Indeed, in schizophrenia, suicide is the com-
monest cause of premature death [11,12]. Even though
SMDs have a relatively low prevalence (1-2%), a recent re-
view estimated that up to 12 percent of all deaths due to
suicide are attributable to schizophrenia [13]. People with
schizophrenia are more likely to use serious and violent
methods in response to hallucinatory voices and delusions
compared to patients with major depression [14].
Suicide might be a hidden cause of death in traditional
societies because of the high levels of stigma and associated
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religious and cultural condemnation [15,16]. However,
most research on suicide has been carried out in the more
affluent countries [9,17,18]. Furthermore, most studies from
traditional societies focus on suicide in the general popula-
tion [6,19], and there is extremely limited information on
the epidemiology of fatal and non-fatal suicidal behavior
among people with SMD [20,21]. Factors contributing
to this situation include poorly developed and under-
resourced systems to collect and report data on suicide,
coupled with religious and cultural sensitivities that ren-
der reporting unacceptable [15,16]. The few existing re-
ports of suicide and suicide attempts in people with SMD
in LMICs are restricted to patients attending psychiatric
facilities, where selection bias is high due to barriers to
help seeking and the large treatment gap [22,23].
In studies conducted in Ethiopia, the lifetime prevalence
of attempted suicide was found to be 3.2% for a rural adult
population in Butajira [15], 0.9% for an urban community
in Addis Ababa [24], 14.3% for a high school student
population [25] and 19.2% for a psychiatric out-patient
clinic attendants [23]. Earlier hospital-based studies from
Ethiopia, reported higher rates of suicide attempts among
younger age groups [26,27]. In a systematic study of police
and hospital records from Addis Ababa, the rate of com-
pleted suicide was found to be 7.76/100,000 persons per
year [27], with higher rates of attempts in males. . There
are no studies from Ethiopia looking at suicidal behavior
in people with SMD.
In this paper, we report on suicide attempts, completed
suicide and associated factors based on prospective data
gathered from a large, population-based cohort of people
with SMD in rural Ethiopia, who have been under con-
tinuous follow-up for over 10 years. The objectives were
to quantify suicidal behaviors and identify risk factors that
may be amenable to intervention. We hypothesized that
the rate of suicide attempts and completed suicide would
be lower than that found in high income countries due to
strong social cohesion and support systems.
Methods
Setting
This study is part of the Butajira Study on Course and
Outcome of Severe Mental Disorders in Ethiopia, which
has been described in detail previously [28]. The Butajira
district is located about 135 km south of Addis Ababa, the
capital city of Ethiopia. In keeping with the general im-
provement in infrastructure and health service coverage
across the whole country over the past 20 years, access to
health care has expanded markedly in rural Butajira. There
is now one zonal referral hospital, 11 health centers and
over 40 health posts, each staffed by two community-
based health extension workers. Except for one outreach
site run by this research project, psychiatric care is only
rendered at the Butajira referral hospital. Two psychiatric
nurses run this service. Most people in the area use trad-
itional methods for treating SMDs and those who seek
modern treatment usually continue to use these trad-
itional methods in addition to modern care [29]. The main
livelihood for people in the district is farming, with the
cash crops of khat (an amphetamine-like stimulant) and
chilli peppers grown in the highland and lowland areas,
respectively.
Study design
A population-based cohort study.
Initial recruitment
Initial recruitment of the Butajira cohort occurred between
March 1998 and May 2001. Two-stage screening was car-
ried out in the total adult population of the district aged
between 15 and 49 years (n = 68,378; 83.0% of eligible popu-
lation) in order to identify people with schizophrenia, bipo-
lar I disorder and major depression (MDD) [28,30]. The
psychosis and mood disorder sections of the Composite
International Diagnostic Interview [31] (CIDI) 2.1 were sup-
plemented by the Key Informant method in order to find
possible cases [30]. This was then followed by a diagnostic
clinician interview using the Amharic Version of the Sched-
ules for Clinical Assessment in Neuropsychiatry (SCAN 2.1)
[32]. Additional incident cases were also identified over the
ensuing two years. Patients in this study were followed up
monthly for a period of between 10 to 13 years.
Study population
A total of 919 patients; 358 patients with the diagnosis
of schizophrenia, 216 with MDD and 345 with bipolar I
disorder were included in the study. Seventy-five of
these patients were enrolled in the study as incident
cases; schizophrenia (n = 40), MDD, (n = 8) and bipolar
I disorder (n = 27) over two years after the initial survey
was completed. Although less than 10% of the cohort
had ever used any modern psychiatric service before re-
cruitment, all patients were given free access to basic
psychiatric treatment throughout the follow-up period.
Drug treatment included first generation oral and depot
antipsychotic medications and tricyclic antidepressants.
An outreach service station was also initiated by the
study project so that patients living in distant villages
could access the service on scheduled dates. The psychi-
atric service team included lay project outreach workers
who made monthly home visits, facility-based psychi-
atric nurses and a medical doctor. Psychiatrists provided
telephone consultation or assessed patients in the Butajira
clinic as needed.
Inclusion and exclusion criteria
All patients with established DSM-IV/ICD-10 diagnoses
of schizophrenia, MDD and bipolar I disorder and who
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had at least one follow-up assessment after enrollment
were included in the analysis in this report. Suicidal ges-
ture or attempt was defined as a self-inflicted act associ-
ated with intent to die or use of a method with potential
for lethality.
Follow-up
Patients were followed up for a period varying from one
month to 13 years, with a mean follow-up period of
10 years. Patients who needed treatment were scheduled
to visit the psychiatric clinic monthly. On each monthly
visit the presenting symptoms, examination findings and
prescribed treatments were recorded. Annual research as-
sessments were carried out by psychiatric nurses and med-
ical doctors, including systematic assessment of symptom
profile, diagnosis, treatment and adverse effects of drugs,
changes in work and living arrangements, Global Assess-
ment of Function (GAF) [33] and Family Interview Sched-
ule (FIS) [32].
For the final follow-up assessment, trained psychiatrists
carried out a clinical assessment and completed the Longi-
tudinal Interval Follow-up Evaluation (LIFE) [34] chart for
each person in the cohort. The LIFE-Chart data were gen-
erated from a range of sources, including data from pa-
tients, family members, the baseline and annual follow-up
data, monthly clinic visit notes, the project outreach
workers who made monthly home visits and the psychi-
atric nurses who had treated the patients throughout the
follow-up period. The LIFE-Chart required the psychia-
trists to make retrospective month-by-month ratings of
psychopathology, medication treatment, substance use
and psychosocial functioning. A narrative account sum-
marized the individual patient data over the periods of the
follow-up. Each patient’s baseline and follow-up data were
summarized before contacting the patient. In situations
where patients could not come to the psychiatric clinic for
the final assessment, psychiatrists made home visits to do
the assessments. Data on the timing of completed suicide
was collected continuously during follow-up of the cohort,
with verification and additional information on methods
of suicide obtained at the final LIFE-chart assessment.
Verbal autopsy documents that were completed within
four weeks of report of a patients’ death to determine the
possible immediate cause of death were also included in
the review for the deceased cases.
Consultant psychiatrists (AF and TS) supervised the rat-
ings. One of the psychiatrists (AF) was trained in LIFE-
Chart in a specialized center in the USA and trained the
psychiatrists who completed LIFE Chart.
Data analysis
Completed LIFE-Chart questionnaires were cross-
checked for completeness on a daily basis. The Statistical
Program for Social Science (SPSS version 15) was used
to computerize the data. Data were then transferred to
STATA (version 11) for analysis. Since the amount of
missing data was under 2%, complete case analysis was
carried out. Sociodemographic (age, sex, marital status,
areas of residence, religion, education and having chil-
dren) and clinical factors (diagnosis, percent time on
psychotropic medication, history of alcohol and khat
abuse or dependence, level of functioning at enrollment
measured with the Global Assessment of Functioning)
known to be associated with suicidal behavior were in-
cluded in a multiple logistic regression model. Multivari-
able analysis of factors associated with completed suicide
was not carried out because of the small number of
completed suicide during the follow-up period. Poisson
regression was used to model the incidence of suicide at-
tempt taking number of attempts as an outcome and
duration of follow-up as an offset variable.
Ethical considerations
Ethical approval was obtained from Addis Ababa Uni-
versity, Faculty of Medicine. Study participants provided
consent to participate in the study. Free psychiatric con-
sultation and medication were provided for patients
through the study project.
Results
LIFE chart were completed for a total of 919 participants.
Face to face interviews were carried out by psychiatrists
on 68.2% (n = 627) of the participants. Information for
31.8% (n = 292) of participants relied on data extracted
from follow-up documents, informants who knew the pa-
tient very well and project field staff. Of these 292 patents,
39.7% (n = 116) were still under active follow-up but could
not attend for the LIFE assessment, 40.7% (n = 119) were
deceased by the time of the LIFE interview, 16.4% (n = 48)
had migrated out of the study site and hence were not
traceable and 3.0% (n = 9) were vagrants and could not be
located. The LIFE chart evaluation used clinical and re-
search documents, which were available for all 919 and
face to face interview by psychiatrists carried out to
complete the LIFE chart on 66.5% (n = 627) of the partici-
pants. The face to face assessment and document reviews
were supplemented with collateral information whenever
required.
Suicidal behavior
The prevalence of at least one suicide attempt during
the 10-year period was 20.2% (n = 186), with the number
of attempts ranging from 1 to 5. The ratio of suicide
attempters to completers was 10.3:1. The lifetime preva-
lence of suicide attempt was 26.5% for patients with
MDD, 23.8% for patients with bipolar I disorder and
13.1% for patients with schizophrenia. The overall rate
of suicide attempt was significantly higher among those
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with mood disorders (bipolar disorder and major depres-
sion) compared to those with schizophrenia (x2(1) = 12.5;
p < 0.001). The prevalence of suicide attempts stratified by
patients’ baseline and follow-up characteristics is summa-
rized in Tables 1 and 2. The prevalence of suicide attempt
was higher in women (23.6% vs. 18.2%; p = 0.046), those
who were married (p < 0.001) and those who did not have
a child (p = 0.001).
There was no significant age difference between people
with and without suicidal behavior (see Tables 1 and 2).
There was no significant association between suicidal be-
havior and any of the following variables: family experi-
ence of stigma, caregiver burden, alcohol or khat abuse
during the follow-up period, history of poor treatment ad-
herence or percentage of the follow-up time in episode of
mental disorder or in remission (Tables 1 and 2).
Results from a multivariable logistic regression model
are summarized in Table 3. While the significant univari-
ate association between female gender and suicidal behav-
ior disappeared in the multivariable model (OR = 1.5, 95%
CI = 0.69, 1.59) other factors were significantly associated
with the odds of suicidal behavior. Being at least 40 years
of age at enrollment was inversely associated with odds of
Table 1 Baseline and follow-up characteristics of people
with severe mental disorders who attempted or
completed suicide over the 10-year follow-up period
(categorical variables)
Characteristics Total sample
(n = 919)
Exhibited suicidal
behavior (n = 186)
N N % p-value
Baseline characteristics
Gender
Male 572 104 18.2 0.046
Female 347 82 23.6
Age group at
enrollment (years)
<20 92 18 19.6 0.577
20-29 349 65 18.6
30-39 306 70 22.9
>40 160 31 19.4
Marital status
Never married 347 47 13.5 <0.001
Married 449 116 25.8
Widowed, divorced
or separated
109 21 19.3
Child status
None 479 118 24.6 0.001
1 or more child 440 68 15.5
Educational status
Non-literate 573 124 21.6 0.206
Literate 331 60 18.1
Employment
Unemployed 429 80 18.7 0.261
Employed 490 106 21.6
Religion
Muslim 644 121 18.8 0.212
Orthodox Christian 222 52 23.4
Protestant Christian 51 13 25.5
Area of residence
Urban 187 34 18.2 0.433
Rural 732 152 20.8
Speed of illness onset
Acute (within 3-months) 638 143 22.4 0.133
Insidious (3-12 months) 83 15 18.1
Insidious (>12 months) 82 11 13.4
Diagnosis
Schizophrenia 358 47 13.1 <0.001
Bipolar I Disorder 345 82 23.8
Major Depressive Disorder 216 57 26.3
Table 1 Baseline and follow-up characteristics of people
with severe mental disorders who attempted or
completed suicide over the 10-year follow-up period
(categorical variables) (Continued)
Follow-up characteristics
% of follow-up receiving
psychotropic medication
≥50% of follow-up period 198 42 21.2 0.701
<50% of follow-up period 721 144 20.0
Percentage of time
adherent to medication
<25% 182 43 23.6 0.348
25-49% 106 27 25.5
50-75% 156 29 18.6
>75% 338 63 18.6
Not prescribed 136 24 17.7
History of alcohol/khat
abuse or dependence
No 750 148 19.7 0.421
Yes 169 38 22.5
Level of social functional
impairment on last
assessment
No impairment 208 42 20.2 0.094
Mild impairment 97 25 25.8
Moderate 174 43 24.7
Severe 440 76 17.3
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suicide attempts (OR = 0.41, CI = 0.18, 0.93). Compared to
people who had never married, those who were married
had an increased odds of having one or more suicide at-
tempts (OR = 2.17, CI = 1.21, 3.91). Compared to patients
with the diagnosis of schizophrenia, patients with the diag-
nosis of bipolar I disorder (OR = 2.59, CI = 1.57, 4.26) and
those with the diagnosis of MDD (OR = 2.71, CI = 1.60,
4.58) had an increased odds of suicide attempts. Having a
history of alcohol or khat abuse was also associated signifi-
cantly with increased odds of suicide attempts (OR = 1.84,
CI = 1.14, 2.96). Higher baseline GAF scores were associ-
ated with lower odds of suicide attempts (OR = 0.99, CI =
0.98, 0.99). Compared to those who only attempted sui-
cide, those who successfully committed suicide were likely
to be men, to receive a diagnosis of schizophrenia and to
be on treatment for longer (Table 4). In relation to inci-
dence of suicide attempt, increased incidence rate was as-
sociated with marriage and loss of marriage, having a
diagnosis of mood disorders (both bipolar and major de-
pressive disorder), history of substance abuse, receipt of
psychotropic medications for a prolonged period and ill-
ness severity at enrollment (Table 5). The interaction of
baseline severity of illness and treatment status was not
significant; however the inclusion of the interaction term
resulted in non-significance of the effect of treatment dur-
ation on the incidence of suicide attempt.
Completed suicide
Hanging was the most frequent method used by both
attempters and completers groups (71.5%), followed by
drowning (19.9%) and organophosphate poisoning (14%).
Twenty-nine patients (15.6%) used multiple methods in an
attempt to end their life. Patients with a diagnosis of bipo-
lar I disorder or schizophrenia used more aggressive
methods; jumping from a height, hanging, and drowning
by falling into narrow water wells (Figure 1). There was no
apparent difference in method between those who died
and those who survived from the attempts.
Male gender was associated significantly with suicide at-
tempt that resulted in a fatal outcome [16.2% (n = 17) in
males compared with 2.4% (n = 2) in females; p = 0.002)].
Of suicide attempts, the percentage resulting in death was
significantly lower in patients with diagnoses of MDD or bi-
polar I disorder compared to patients with schizophrenia:
18.8% (n = 9) in schizophrenia, 9.9% (n = 8) in bipolar I dis-
order and 3.5% (n = 2) in MDD; (p-value = 0.036). Over
the10-years of follow-up, the percentage of patients com-
mitting suicide was 2.5% for schizophrenia, 2.3% for bipolar
I disorder and 0.92% for MDD. The incidence of death
from suicide was highest for patients with a diagnosis of
schizophrenia (253.7/100,000 person years of follow-up,
CI = 116.1, 481.0), followed by bipolar I disorder (216.5,
95% CI = 93.5, 426.1) and MDD (89.1, 95% CI = 10.8,
321.4). The overall incidence of completed suicide in the
cohort was 200.2/100,000 person-years (CI = 120.6, 312.5).
Suicide attempts were increased in patients who had re-
ceived recommended treatment for ≤50% of their follow-
up time (93.1%; n = 135) compared to those who received
recommended treatment for more than 50% of their
follow-up time. Fatal outcome of a suicide attempt was in-
creased in patients who had received treatment for more
than 50% of their follow-up time compared to those who
Table 2 Baseline and follow-up characteristics of people with severe mental disorders who attempted or completed
suicide over the 10-year follow-up period (continuous variables)
Non-attempters Attempters and completers
Number Mean (SE) Number Mean (SE) P-value
Baseline characteristics
Enrollment global assessment of functioning score 733 45.5 (0.81) 186 45.3 (0.79) 0.919
Age at first clear recognition of symptoms (years) 706 22.9 (0.34) 179 22.3 (0.32) 0.460
Carer burden 677 1.2 (0.03) 168 1.1 (0.04) 0.461
Carer stigma experience score 676 0.6 (0.2) 168 0.5 (0.2) 0.328
Follow-up characteristics
Schizophrenia
Mean % time in episode 312 28.7 (1.88) 47 26.4 (1.80) 0.654
Mean % time in remission 312 30.3 (2.00) 47 34.8 (2.04) 0.423
Bipolar I
Mean % time in episode 263 3.0 (0.50) 82 3.3 (0.46) 0.762
Mean % time in remission 263 78.3 (2.08) 82 78.4 (1.92) 0.982
Depression
Mean % time in episode 158 6.6 (1.40) 57 8.1 (1.23) 0.565
Mean % time in remission 158 80.3 (2.10) 57 74.1 (2.47) 0.147
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received treatment for ≤50% of the follow-up time [21.4%
(n = 9) versus 6.9% (n = 10); p = 0.006]. Almost all patients
in the fatal outcome group (n = 17; 90.0%) had symptoms
suggestive of acute illness in the week preceding their
death, while only 52.6% (n = 10) were taking their medica-
tions regularly around the time when death occurred.
Discussion
The incidence of completed suicide and suicide attempts in
this large, population-based, clinician-diagnosed cohort of
people with SMD in rural Ethiopia was comparable to that
seen in people with SMD in high-income country settings
[2,18]. Despite the potential under-reporting of suicide
Table 3 Univariate and multivariable analysis of factors associated with suicidal behavior (attempted or completed
suicide) during the course of follow-up among the Butajira cohort
Characteristics Crude OR 95% CI p-value Adjusted OR 95% CI p-value
Gender
Female Ref. Ref.
Male 0.71 0.52,0.99 0.047 1.05 0.69,1.59 0.825
Age group at enrolment (years)
<20 Ref. Ref.
20-29 0.94 0.53,1.68 0.837 0.66 0.35,1.26 0.210
30-39 1.22 0.68,2.18 0.503 0.65 0.32,1.31 0.228
≥40 0.99 0.51,1.89 0.971 0.41 0.18,0.93 0.033
Marital status
Never married Ref. Ref.
Married 2.22 1.53,3.23 <0.001 2.17 1.21,3.91 0.010
Separated/divorce/widowed 1.52 0.86,2.68 0.146 1.69 0.86,3.33 0.130
Having children
No Ref. Ref.
Yes 1.79 1.28,2.49 0.001 1.20 0.70,2.01 0.508
Educational status
Non-literate Ref. Ref.
Literate 0.80 0.57,1.13 0.207 0.85 0.57,1.28 0.441
Religion
Muslim Ref. Ref.
Christian 0.76 0.52,1.09 0.137 0.69 0.46,1.03
Protestant 1.12 0.55,2.26 0.755 1.21 0.58,2.54 0.607
Area of residence
Urban Ref. Ref.
Rural 1.18 0.78,1.78 0.433 1.01 0.64,1.60 0.957
Diagnosis
Schizophrenia Ref. Ref.
Bipolar I 2.07 1.40,3.07 <0.001 2.59 1.57,4.26 <0.001
MDD 2.39 1.56,3.69 <0.001 2.71 1.60,4.58 <0.001
History of alcohol/khat abuse
Absent Ref. Ref.
Present 1.18 0.79,1.77 0.422 1.84 1.14-2.96 0.013
Follow-up treatment status
Received treatment for < 50% of the follow-up period Ref. Ref.
Received treatment for > 50% of the follow-up period 1.08 0.73,1.59 0.701 1.45 0.95,2.24 0.088
Global assessment of functioning score at enrollment 1.00 0.99,1.01 0.918 0.99 0.98, 0.997 0.009
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behavior in many societies [15,35], suicide is a global public
health problem and mental illness is known to be the stron-
gest risk factor [36]. In this study, suicide attempts were
more commonly seen in people with mood disorders, espe-
cially MDD, compared to those with schizophrenia; how-
ever, amongst suicide attempters, completed suicide was
substantially higher in people with schizophrenia. This find-
ing is in line with other follow-up studies that reported sig-
nificantly higher rates of suicide attempt among patients
with depression [37].
The 10 year prevalence of suicide attempts in patients
with major depression (26.5%) found in this study is higher
than the lifetime prevalence of around 16% in people with
MDD reported in clinic-based studies in some high-income
countries [38]. However, the finding on bipolar disorder is
Table 4 Factors associated with fatal outcome in suicide
attempters
Characteristics Non-fatal
outcome
Fatal
outcome
p-value
Number (%) Number (%)
Baseline demographics
Gender
Male 88 (83.8) 17 (16.2) 0.002
Female 80 (97.6) 2 (2.4)
Age group at enrolment
<20 17 (89.5) 2 (10.5) 0.590
20-29 58 (89.2) 7 (10.8)
30-39 65 (92.9) 5 (7.1)
>40 26 (83.9) 5 (16.1)
Marital status
Never married 42 (87.5) 6 (12.5) 0.840
Married 105 (90.5) 11 (9.5)
Others 19 (90.5) 19 (10.3)
Religious affiliation
Orthodox Christian 45 (86.5) 7 (13.5) 0.349
Muslim 110 (90.2) 12 (9.8)
Protestant 13 (100) 0 (0)
Area of residence
Urban 31 (91.2) 3 (8.8) 0.775
Rural 137 (89.5) 16 (10.5)
Child status
No children 61 (88.4) 8 (11.6) 0.620
At least one child 107 (90.7) 11 (9.3)
Caregiver experience at baseline
Stigma score Mean =1.09 Mean =1.28 0.452
SE = 0.08 SE = 0.30
Burden score Mean =0.54 Mean =0.43 0.396
SE = 0.04 SE = 0.12
Clinical features at baseline
Diagnosis
Schizophrenia 39 (81.3) 9 (18.8) 0.036
Bipolar-I Disorder 74 (90.2) 8 (9.8)
Major Depressive Disorder 55 (96.5) 2 (3.5)
History of suicidal
thoughts at enrolment
Absent 97 (90.7) 10 (9.4) 0.943
Present 56 (90.3) 6 (9.7)
History of suicidal
attempts at enrolment
Absent 129 (91.5) 12 (8.5) 0.133
Present 23 (82.1) 5 (17.9)
Table 4 Factors associated with fatal outcome in suicide
attempters (Continued)
GAF score at baseline Mean = 45.5 Mean = 45.3, 0.919
SE = 0.82 SE = 1.6
Age at first clear
recognition of symptoms
Mean =22.2 Mean = 23.6 0.499
SE = 0.7 SE = 1.4
Clinical features during follow-up
Schizophrenia illness
course (n = 312)
% time in psychotic episode Mean =25.8 Mean =37.5 0.344
SE = 5.0 SE = 13.8
%time in remission Mean =24.4 Mean =32.2 0.871
SE = 5.9 SE = 11.5
Bipolar I disorder illness
course (n = 263)
% time in manic or
depressive episode
Mean =3.2 Mean =4.2 0.719
SE = 0.9 SE = 2.8
% time in remission Mean =78.3 Mean =79.9 0.892
SE = 3.6 SE = 11.9
Major depressive
disorder (n = 158)
% time in depressive episode Mean =8.0 Mean =10.5 0.829
SE = 2.1 SE = 7.3
% time in remission Mean =73.5 Mean =90.2 0.460
SE = 4.2 SE = 9.8
Follow-up treatment status
Received treatment for > 50%
of the follow-up period
33 (78.6) 9 (21.4) 0.006
Received treatment for < 50%
of the follow-up period
135 (93.1) 10 (6.9)
Alcohol/khat abuse/
dependence
No 136 (91.3) 139 (8.7) 0.198
Yes 32 (84.2) 6 (15.8)
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comparable with other reports where up to 29% of patients
with bipolar disorder are estimated to attempt suicide at
least once in their life-time [39], with one study reporting a
five year prevalence of 18% [40]. A European longitudinal
study of bipolar disorder patients reported lifetime preva-
lence of suicide attempt of 29.9%, which is comparable to
this study finding and that the risk for suicide attempt in-
creases with increased duration of illness [17]. Although
under-reporting is difficult to avoid, the use of diverse
sources of information to collect the data and the close
monitoring over the follow-up period in our study might
have mitigated the impact of under-reporting. In an earlier
community-based study from the same area of Ethiopia,
the lifetime prevalence of suicide attempt was reported to
be 14.6% in people with minor depressive disorder [41]. In
our study, greater severity of illness is likely to explain the
difference in suicidal behavior and lends indirect validity to
the construct of depression in this setting. Diagnosed MDD
in isolation, or when co-morbid with another axis I dis-
order, is a well-established major risk factor for suicidal be-
havior worldwide [17,38,42].
The rate of suicide attempts in this study was also much
higher than the lifetime prevalence of 6.9% that was re-
ported from the same population at baseline [43]. Longer
duration of illness might explain this difference.
Suicide is common among patients with schizophrenia
and it is estimated that about 10% of patients with schizo-
phrenia will eventually commit suicide and over four times
that number make attempts [44]. Actual reports of preva-
lence of suicide attempts vary from 19.8% [20] to 34.5%
[45]. Our finding of suicide attempt in 13.1% of patients
with the diagnosis of schizophrenia is less than that re-
ported from affluent countries. Most suicidal behavior and
suicide-related deaths in people with schizophrenia occur
in the early phase of the illness, with the risk of death from
suicide estimated to be around 5 or 6% [46,47]. People
with schizophrenia in our cohort had a mean duration of
illness of over 10 years at enrolment, which might have
contributed to low rates of suicidal behavior during the
follow-up period. The overall ratio of attempted to com-
pleted suicide in our study was at the lower end of what is
reported elsewhere for general population studies (8-25:1)
[48]. This was an unexpected finding given the relative le-
thality of methods used for suicide attempts in this setting.
Increased incidence of suicide attempt and a fatal out-
come from a suicide attempt was more likely among pa-
tients who received treatment with psychotropic medication
for more than half of the follow-up time. There could be a
number of possible explanations for the apparently non-
beneficial effect of medication on suicidal behavior in our
study. First, the evidence for beneficial effects of psycho-
tropic medication on reducing suicide attempts and suicide
is largely restricted to antidepressant medication in people
with MDD [38] and mood-stabilizers, particularly Lithium
[49], in people with bipolar disorder [50]. Second, although
treatment with antipsychotic medication improves the qual-
ity of life and reduces symptoms in patients with schizo-
phrenia, evidence for association between treatment with
Table 5 Incidence of suicide attempt and associated factors
Characteristics IRR 95% CI p-value
Gender
Female Ref.
Male 0.99 0.74,1.31 0.920
Age group at enrolment (years)
<20 Ref.
20-29 0.77 0.49,1.23 0.281
30-39 0.91 0.56, 1.50 0.719
≥40 0.90 0.52, 1.56 0.713
Marital status
Never married Ref.
Married 2.08 1.39,3.10 <0.001
Separated/divorce/widowed 1.83 1.16,2.88 0.009
Having children
No Ref.
Yes 0.88 .63, 1.25 0.491
Educational status
Non-literate Ref.
Literate 0.87 0.66,1.15 0.337
Religion
Muslim Ref.
Orthodox Christian 0.76 0.58,1.00 0.048
Protestant Christian 0.97 0.59,1.62 0.917
Area of residence
Urban Ref.
Rural 0.99 0.73,1.35 0.960
Diagnosis
Schizophrenia Ref.
Bipolar I 1.51 1.07,2.11 <0.018
Major Depressive Disorder 1.84 1.30,2.61 0.001
History of alcohol/khat abuse
Absent Ref.
Present 1.51 1.10,2.08 0.012
Percentage of follow-up
time on treatment
For < 50% of the follow-up time Ref.
For > 50% of the follow-up time 1.38 1.03,1.84 0.030
GAF categories at baseline
60 and above Ref
<60 1.37 1.03,1.81 0.029
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first generation antipsychotic medications and lowering of
suicide risk is inconclusive [13]. This is also true for other
antipsychotic medications, except for clozapine, which is ap-
proved by the FDA for treatment of suicidal behavior in
schizophrenia and schizoaffective patients [51]. In this study,
most completed suicides (47.4%) occurred in people with
schizophrenia. Furthermore, mood stabilizer medication
was not available for the vast majority of patients; instead,
people with bipolar disorder were treated with a combin-
ation of first generation antipsychotic medication and anti-
depressant medications. Perhaps the most likely explanation
for the finding is, however, reverse causality. People with se-
vere clinical symptoms are more likely to be prescribed psy-
chotropic medication and to receive medication for longer
periods of time. For example, higher level of functional im-
pairment and symptomatology measured with the GAF at
baseline was associated with an increased incidence of sui-
cide attempts (Table 5).
The burden from suicide, due to loss of potential years
of life, and the associated economic and societal conse-
quences are more pronounced for younger age groups.
This has been shown in many general population studies
[19,52,53]. Among people with SMD in our study, we ob-
served no significant difference in the mean age of suicide
attempters compared to those who never attempted sui-
cide, and between attempters and completers. Those who
completed suicide were distributed across all age groups
in this population, possibly because having a psychiatric
disorder itself is a risk factor, independent of age and other
factors [37,54].
Despite the widely held belief that people who are mar-
ried and have a more stable life have lower rates of suicide
attempts and completed suicide [44,55,56], there are con-
troversies around this finding. While increased suicide risk
has been reported for separated, divorced and widowed
populations in other studies of suicide in people with SMD
in LMICs [13,20], earlier Ethiopian study conducted in the
capital city did not find any association between suicide
attempt with marital status [24]. In a general population
study from India, being separated, divorced or widowed was
protective against suicide in women [19]. A case-control
study from Pakistan also found marriage to increase the
risk of suicide [57]. The finding that married people had
significantly more suicide attempts in this study after
adjusting for confounders might be a real reflection of the
stressful life situation in LMICs for people who are married,
independent of age and gender. An earlier study from the
same area reported intimate partner violence to be a risk
factor for suicide attempt [58]. We did not have data on do-
mestic violence to look into the association between suicide
attempt and domestic violence among married women.
The findings that male gender, young age and previous
history of suicidal attempt were associated with increased
risk of suicide accorded with established findings across
schizophrenia studies [13,42,44,45,47]. Past history of sui-
cidal attempt is also reported to be a risk factor for sui-
cidal behavior in mood disorder patients as well [59], but
did not show any significant association in our study,
which might be because of the small number of fatal out-
comes in our study population.
In contrast to other studies, less than 20.0% of our
study population had a history of alcohol or other sub-
stance abuse. Furthermore, most substance misuse was
limited to chewing khat leaves (amphetamine like sub-
stance), which is grown widely in the area. The associ-
ation between history of alcohol and substance abuse
and suicidal behavior is a well-established finding in
general population studies and psychiatric patients
with different diagnosis [9,17,42,45,60] and our finding
is in line with these studies.
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Figure 1 Mode of suicide attempt in completers and attempters only (Other: includes medication overdose (1 patient who was a
completer), holding live electricity wires and cables, running into moving vehicles and stabbing).
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The finding that suicide attempt was a more frequent
phenomenon among female patients and completed sui-
cide was significantly more common among male patients
in our study also concurs with other studies [8,17,19,39].
Violent methods of attempt seem to be more import-
ant than the number of attempts in our population as
16/19 (84.2%) of the patients with completed suicide did
so at the first attempt where almost all male patients
used aggressive methods such as jumping from a height,
hanging and drowning. The finding that hanging is the
commonest method used is in agreement with other
studies in Ethiopia [23,24] and in the Butajira area [15].
Methods such as self poisoning with organophosphate
chemicals and drowning are also commonly reported
and have a potential for prevention. With the govern-
ment’s policy of encouraging farmers to increase their
yields using pesticides and fertilizers, there might be in-
creased access to such chemicals in remote rural areas,
increasing the risk of death from attempted suicide.
Prevention of access to common methods of suicide,
especially restricting access to pesticides, and providing
treatment for depression and alcohol use disorders has
been recommended by earlier researchers from LMICs
[2,19,61]. In most clinical studies of deliberate self-harm
and suicide attempts in Ethiopia, attempters commonly
used organophosphate pesticide [22,27,62], which is
highly lethal and can be taken impulsively in situations
of interpersonal disputes [63]. Death secondary to
drowning occurred in our study population in situations
where there are deep water wells, with narrow tops, at
the backyards of the residential houses in lowland areas
and in nearby rivers during the rainy season.
Limitations of this study are that we were restricted to
consideration of axis-I disorders during the follow-up.
Other factors of potential importance, such as personal-
ity disorder, major life-events, stressful life situations and
physical illnesses, were not explored. Data presented in
this study were combined for all diagnostic categories
because of the small number of patients that died from
suicide in each group.
Conclusions
Suicide and suicidal behavior are shown to be common
problems in this cohort and severe mental disorders are
important risk factors for the behavior. Some of the
methods used in this setting are preventable. Our find-
ings indicate that the new government initiative to scale
up access to mental health care in Ethiopia also needs to
focus on prevention of access to methods of suicide, par-
ticularly in people with SMD. Some counter-intuitive
findings such as increased risk in married persons and
the role of extended family for the subjects in question
might need to be examined in further studies and their
underlying mechanisms should be explored.
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